000 01140 a2200373 4500
005 20250512221031.0
264 0 _c19840314
008 198403s 0 0 eng d
022 _a0028-3878
024 7 _a10.1212/wnl.34.2.198
_2doi
040 _aNLM
_beng
_cNLM
100 1 _aWard, C D
245 0 0 _aL-dopa decarboxylation in chronically treated patients.
_h[electronic resource]
260 _bNeurology
_cFeb 1984
300 _a198-201 p.
_bdigital
500 _aPublication Type: Journal Article
650 0 4 _aAdult
650 0 4 _aCarbidopa
_xtherapeutic use
650 0 4 _aChemistry, Organic
650 0 4 _aDecarboxylation
650 0 4 _aDose-Response Relationship, Drug
650 0 4 _aFemale
650 0 4 _aHumans
650 0 4 _aLevodopa
_xmetabolism
650 0 4 _aMale
650 0 4 _aOrganic Chemistry Phenomena
650 0 4 _aParkinson Disease
_xdrug therapy
650 0 4 _aTime Factors
700 1 _aTrombley, I K
700 1 _aCalne, D B
700 1 _aKopin, I J
773 0 _tNeurology
_gvol. 34
_gno. 2
_gp. 198-201
856 4 0 _uhttps://doi.org/10.1212/wnl.34.2.198
_zAvailable from publisher's website
999 _c6537879
_d6537879